These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 7982239)
21. Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer. Jaques G; Auerbach B; Pritsch M; Wolf M; Madry N; Havemann K Cancer; 1993 Jul; 72(2):418-25. PubMed ID: 8391379 [TBL] [Abstract][Full Text] [Related]
22. Serum levels of VEGF-C, VEGF-D, and sVEGF-R2 in patients with lung cancer during chemotherapy. Naumnik W; Izycki T; Swidzińska E; Ossolińiska M; Chyczewska E Oncol Res; 2007; 16(9):445-51. PubMed ID: 18074680 [TBL] [Abstract][Full Text] [Related]
23. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Kaynar H; Meral M; Turhan H; Keles M; Celik G; Akcay F Cancer Lett; 2005 Sep; 227(2):133-9. PubMed ID: 16112416 [TBL] [Abstract][Full Text] [Related]
24. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer. Schneider J; Philipp M; Salewski L; Velcovsky HG Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474 [TBL] [Abstract][Full Text] [Related]
25. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer]. Wu Y; Wu Y; Wang L; Qu L Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921 [TBL] [Abstract][Full Text] [Related]
26. Raised serum urea predicts for early death in small cell lung cancer. Winter MC; Potter VA; Woll PJ Clin Oncol (R Coll Radiol); 2008 Dec; 20(10):745-50. PubMed ID: 18845424 [TBL] [Abstract][Full Text] [Related]
27. Soluble Fas and Fas ligand provide new information on metastasis and response to chemotherapy in SCLC patients. Shimizu M; Kondo M; Ito Y; Kume H; Suzuki R; Yamaki K Cancer Detect Prev; 2005; 29(2):175-80. PubMed ID: 15829378 [TBL] [Abstract][Full Text] [Related]
28. Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltration. Ledermann JA; Pasini F; Olabiran Y; Pelosi G Int J Cancer Suppl; 1994; 8():49-52. PubMed ID: 7515029 [TBL] [Abstract][Full Text] [Related]
29. Coexpression of ganglioside antigen Fuc-GM1, neural-cell adhesion molecule, carcinoembryonic antigen, and carbohydrate tumor-associated antigen CA 50 in lung cancer. Brezicka FT; Olling S; Bergman B; Berggren H; Engström CP; Hammarström S; Holmgren J; Larsson S; Lindholm L Tumour Biol; 1992; 13(5-6):308-15. PubMed ID: 1337798 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of homocysteine as a cancer marker: total thiol compounds and folate levels in untreated lung cancer patients. Ozkan Y; Yardim-Akaydin S; Firat H; Calişkan-Can E; Ardiç S; Simşek B Anticancer Res; 2007; 27(2):1185-9. PubMed ID: 17465261 [TBL] [Abstract][Full Text] [Related]
31. Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis. Boher JM; Pujol JL; Grenier J; Daurès JP Br J Cancer; 1999 Mar; 79(9-10):1419-27. PubMed ID: 10188885 [TBL] [Abstract][Full Text] [Related]
32. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients. Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320 [TBL] [Abstract][Full Text] [Related]
33. Expression of CEA and trophoblastic cell markers by lung carcinoma in association with histological characteristics and serum marker levels. Slodkowska J; Szturmowicz M; Rudzinski P; Giedronowicz D; Sakowicz A; Androsiuk W; Zakrzewska-Rowinska E Eur J Cancer Prev; 1998 Feb; 7(1):51-60. PubMed ID: 9511851 [TBL] [Abstract][Full Text] [Related]
34. Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Bharti A; Ma PC; Maulik G; Singh R; Khan E; Skarin AT; Salgia R Anticancer Res; 2004; 24(2C):1031-8. PubMed ID: 15154618 [TBL] [Abstract][Full Text] [Related]
35. [Clinical usefulness of a new tumor marker CYFRA21-1 in patients with lung cancer]. Li R; Li R; Wang Y Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):26-9. PubMed ID: 11263296 [TBL] [Abstract][Full Text] [Related]
36. Carbohydrate antigens in human lung carcinomas. Nilsson O APMIS Suppl; 1992; 27():149-61. PubMed ID: 1520524 [TBL] [Abstract][Full Text] [Related]
37. Value of tumour and inflammatory markers in lung cancer. Oremek GM; Sauer-Eppel H; Bruzdziak TH Anticancer Res; 2007; 27(4A):1911-5. PubMed ID: 17649794 [TBL] [Abstract][Full Text] [Related]
38. [The importance of measuring plasma carcinoembryonic antigen in small-cell anaplastic carcinoma]. Michetti G; Bamberga M; Pugliese C; Ori Belometti M; Arnone P; Minio A; Ciaravino G; Villa R; Alesina R; Cottini M Minerva Med; 1994 May; 85(5):231-6. PubMed ID: 8028751 [TBL] [Abstract][Full Text] [Related]
39. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients. Lai CL; Tsai CM; Tsai TT; Kuo BI; Chang KT; Fu HT; Perng RP; Chen JY Clin Cancer Res; 1998 Dec; 4(12):3025-30. PubMed ID: 9865916 [TBL] [Abstract][Full Text] [Related]
40. Determining the cut-off value of pro-gastrin releasing peptide (ProGRP) in lung cancer according to population characteristics. Bubanović G; Pavićević R; Franjević A Coll Antropol; 2008 Dec; 32(4):1155-64. PubMed ID: 19149223 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]